UMP Healthcare Holdings Limited logo

UMP Healthcare Holdings Limited

0722.HK

HKSEHealthcareMedical - Care Facilities

Latest quote

HK$0.45

HK$0.00 · 0.00%

Aug 21, 2:35 PM HKTData delayed

0722.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

UMP Healthcare Holdings Limited, an investment firm, delivers a broad spectrum of medical and wellness provisions across Hong Kong, Macau, and mainland China. The company's operations are divided into two main divisions: Corporate Healthcare Solution Services and Clinical Healthcare Services. Its extensive service portfolio encompasses virtual medical support, general family practice, and specialized consultations covering diverse fields like internal medicine, surgery, pediatrics, cardiology, dermatology, ENT, orthopedics, ophthalmology, urology, gastroenterology, endocrinology, and diabetes. Additionally, it provides comprehensive dental services, including implants, cosmetic procedures, periodontal care, and orthodontics, alongside traditional Chinese medicine. The company further extends its offerings to include physiotherapy, addressing muscle strengthening, limb and hand function, and eye-hand coordination. Other key services feature day surgery and endoscopy, advanced diagnostic imaging and laboratory testing, health assessments, visa-required medical examinations, immunization and advisory services, vision correction and optometry, reconstructive and aesthetic surgeries (plastic, head, and neck), dermatological and cosmetic treatments, ongoing chronic disease management, and COVID-19 screening. Furthermore, UMP Healthcare is involved in delivering training and advisory services within the healthcare sector. Its client base includes insurance providers, corporate clients, and individual self-paying patients. The organization maintains a vast network of roughly 1,100 directly owned and partnered service facilities. Established in 1990, UMP Healthcare Holdings Limited has its main offices situated in Central, Hong Kong.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
HK
CEO
Cheuk Kwan Kwok
Listed since
Nov 27, 2015
Employees
452

Market position

52-week range

Current HK$0.45

Open
HK$0.45
Previous close
HK$0.45
Volume
26K
0.45× average
Average volume
58.29K
Average daily volume
Market cap
364.93M HKD
Beta
0.33
Market reference 1
50-day average
HK$0.4495
+0.11% above average
200-day average
HK$0.4642
-3.06% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
237.9M HKD
P/E (TTM)
11×
P/B (TTM)
0.47×
P/S (TTM)
0.5×
EV / EBITDA
2.96×
Earnings yield
8.29%
Free cash flow yield
35.28%
Dividend yield
7.33%

Profitability & efficiency

Gross margin
67.75%
Operating margin
29.89%
Net margin
4.41%
Return on equity
4.23%
Return on assets
2.87%
Return on invested capital
18.40%

Financial health

Debt / equity
0.15×
Current ratio
1.99×
Altman Z-score
2.78
Piotroski F-score
8 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends101%66%31%-4%Gross margin, FY2020: 73.93%Gross margin, FY2021: 69.64%Gross margin, FY2022: 69.07%Gross margin, FY2023: 92.49%Gross margin, FY2024: 67.45%Operating margin, FY2020: 16.92%Operating margin, FY2021: 12.27%Operating margin, FY2022: 9.17%Operating margin, FY2023: 12.75%Operating margin, FY2024: 30.00%Net margin, FY2020: 5.64%Net margin, FY2021: 10.83%Net margin, FY2022: 8.31%Net margin, FY2023: 5.43%Net margin, FY2024: 4.32%FY2020FY2021FY2022FY2023FY2024
Gross margin FY2020 73.93%. Gross margin FY2021 69.64%. Gross margin FY2022 69.07%. Gross margin FY2023 92.49%. Gross margin FY2024 67.45%. Operating margin FY2020 16.92%. Operating margin FY2021 12.27%. Operating margin FY2022 9.17%. Operating margin FY2023 12.75%. Operating margin FY2024 30.00%. Net margin FY2020 5.64%. Net margin FY2021 10.83%. Net margin FY2022 8.31%. Net margin FY2023 5.43%. Net margin FY2024 4.32%.

Income trends

Revenue

727.36M HKD-2.82%

Operating income

218.23M HKD+128.75%

Net income

31.44M HKD-22.64%
Income trends across reported periods820.19M HKD533.37M HKD246.55M HKD−40.26M HKDRevenue, FY2020: 617.16M HKDRevenue, FY2021: 666.2M HKDRevenue, FY2022: 727.75M HKDRevenue, FY2023: 748.49M HKDRevenue, FY2024: 727.36M HKDOperating income, FY2020: 104.41M HKDOperating income, FY2021: 81.75M HKDOperating income, FY2022: 66.77M HKDOperating income, FY2023: 95.4M HKDOperating income, FY2024: 218.23M HKDNet income, FY2020: 34.83M HKDNet income, FY2021: 72.17M HKDNet income, FY2022: 60.45M HKDNet income, FY2023: 40.64M HKDNet income, FY2024: 31.44M HKDFY2020FY2021FY2022FY2023FY2024
Revenue FY2020 617.16M HKD. Revenue FY2021 666.2M HKD. Revenue FY2022 727.75M HKD. Revenue FY2023 748.49M HKD. Revenue FY2024 727.36M HKD. Operating income FY2020 104.41M HKD. Operating income FY2021 81.75M HKD. Operating income FY2022 66.77M HKD. Operating income FY2023 95.4M HKD. Operating income FY2024 218.23M HKD. Net income FY2020 34.83M HKD. Net income FY2021 72.17M HKD. Net income FY2022 60.45M HKD. Net income FY2023 40.64M HKD. Net income FY2024 31.44M HKD.
Metric (HKD)FY2024FY2023FY2022FY2021FY2020
Revenue727.36M HKD748.49M HKD727.75M HKD666.2M HKD617.16M HKD
Cost of goods sold236.75M HKD56.24M HKD225.06M HKD202.25M HKD160.89M HKD
Gross profit490.61M HKD692.25M HKD502.69M HKD463.95M HKD456.28M HKD
Selling, general, and administrative272.38M HKD269.4M HKD269.44M HKD249.11M HKD227.77M HKD
Operating expenses272.38M HKD287.54M HKD269.44M HKD249.11M HKD227.77M HKD
Interest income5.01M HKD5.54M HKD3.39M HKD1.35M HKD3.28M HKD
Interest expense7.35M HKD6.94M HKD5.68M HKD3.92M HKD3.22M HKD
Depreciation and amortization42.75M HKD113.79M HKD103.89M HKD78.62M HKD76.87M HKD
Operating income218.23M HKD95.4M HKD66.77M HKD81.75M HKD104.41M HKD
Net income31.44M HKD40.64M HKD60.45M HKD72.17M HKD34.83M HKD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
0.02

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.090.070.040.02Q4 '21Q2 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25Q4 '25
Q4 2021, reported Dec 31, 2021: actual 0.04, estimate —, surprise —, Comparison unavailable. Q2 2022, reported Jun 30, 2022: actual 0.033, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Feb 24, 2023: actual 0.054, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Sep 21, 2023: actual 0.022, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Feb 28, 2024: actual 0.02, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Sep 26, 2024: actual 0.031, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 27, 2025: actual 0.022, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Dec 31, 2025: actual 0.024, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates638.14M519.8M401.45M283.11MQ4 '21No estimateQ2 '22No estimateQ1 '23MissQ3 '23MissQ1 '24MissQ3 '24No estimateQ1 '25No estimateQ4 '25No estimate
Q4 2021, reported Dec 31, 2021: actual 358.21M HKD, estimate —, surprise —, Comparison unavailable. Q2 2022, reported Jun 30, 2022: actual 307.65M HKD, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Feb 24, 2023: actual 365.1M HKD, estimate 613.6M HKD, surprise -40.50%, Miss. Q3 2023, reported Sep 21, 2023: actual 362.07M HKD, estimate 613.6M HKD, surprise -40.99%, Miss. Q1 2024, reported Feb 28, 2024: actual 376.05M HKD, estimate 613.6M HKD, surprise -38.71%, Miss. Q3 2024, reported Sep 26, 2024: actual 373.96M HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 27, 2025: actual 371.46M HKD, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Dec 31, 2025: actual 367.53M HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.033

2025 complete year-13.2% since 2021

2026 partial: HK$0.014

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend Mar 16, 2026

HK$0.014

Semi-Annual

Record Mar 18, 2026 · Payment Apr 15, 2026

Dividend

Ex-dividend Dec 9, 2025

HK$0.019

Semi-Annual

Record Dec 11, 2025 · Payment Jan 9, 2026

Dividend

Ex-dividend Mar 17, 2025

HK$0.014

Semi-Annual

Record Mar 19, 2025 · Payment Apr 11, 2025

Dividend

Ex-dividend Dec 10, 2024

HK$0.02

Semi-Annual

Record Dec 12, 2024 · Payment Jan 10, 2025

Dividend

Ex-dividend Mar 18, 2024

HK$0.013

Semi-Annual

Record Mar 20, 2024 · Payment Apr 19, 2024

Dividend

Ex-dividend Dec 5, 2023

HK$0.03

Semi-Annual

Record Dec 7, 2023 · Payment Jan 5, 2024

0722.HK peers

Continue in GoAI

Research 0722.HK

research.disclaimer